Innovation

Driven by our passion for what we do, our autonomy in how we find solutions, and the strength of our R&D structure we can take on the most complex challenges in healthcare.

Innovation across the Roche Group

Our close strategic partnerships across the Group, and our diverse mix of autonomous innovation engines gives us a rich diversity of expertise and scientific thinking, as we seek to discover and develop solutions to the biggest questions in healthcare today.

13 billion

CHF invested in R&D in 2024

17

countries with Roche innovation centers

>100,000

dedicated employees

Roche Group Innovation Engines

To discover and develop the next breakthroughs, we have built a network of independent innovation engines around the world.

Innovation process

It's a long way from an idea to medical innovation. Here's how we get there.

With patient and societal health needs in mind, we leverage our passion and curiosity for science to create revolutionary medicines that can change patients' lives.

Hans Clevers

Head of Roche Pharma Research and Early Development (pRED)

Great people join us because they want to work on the hardest problems in science.

Aviv Regev

Head of Genentech Research and Early Development (gRED)

The development of transformative therapeutics and diagnostics is a tough business... This is something that the unique structure of the Roche Group really provides.

Palani Kumaresan

Head of Roche Diagnostics Solutions

The benefit of being part of the Roche Group is the huge amount of expertise, experience and resources that we have across the company.

Tom Albert

Global Head of Research and Early Development, Roche Diagnostics Solutions

It is the tremendous diversity of thought and the diversity of decision making within the Roche Group, and across our partnerships, that leads to the development of groundbreaking therapies and diagnostics for patients.

James Sabry

Global Head of Roche Pharma Partnering

Ethical standards

Questions inevitably arise as we explore the potential of cutting-edge technologies. We are committed to adhering to the highest ethical standards in research and development.

How do we meet them

Partnering

Alongside our unique Group structure, our strong network of external partners, drives the creativity and innovation needed for breakthrough research and development

Get to know partnering

See all stories

External innovation opens new doors for advancing science

Global Head of Pharma Partnering James Sabry is excited to embrace the potential of external innovation and innovative partners.

Joining forces in neuroscience

Neurological disorders pose some of the greatest challenges and areas of unmet medical need. We are joining forces with others who are studying these challenges.

Making the Unknown Known

Could comprehensive genomic profiling improve outcomes for patients with one of the most deadly and poorly understood cancers—Cancer of Unknown Primary Origin? A new trial seeks to find out.

Data can change your life; it probably already has

How data can improve and save lives, and why it matters during the COVID-19 crisis and beyond.